LAURENCE MCCULLOUGH to Prenatal Diagnosis
This is a "connection" page, showing publications LAURENCE MCCULLOUGH has written about Prenatal Diagnosis.
Connection Strength
3.474
-
Ethical dimensions of first-trimester fetal aneuploidy screening. Clin Obstet Gynecol. 2014 Mar; 57(1):226-31.
Score: 0.313
-
Authors' response to: Fatally flawed? BJOG. 2013 Feb; 120(3):372-3.
Score: 0.290
-
Critically appraising prenatal genetic diagnosis to prevent disorders of sexual development: an opportunity missed. Am J Bioeth. 2013; 13(10):1-3.
Score: 0.289
-
Letter to the editor regarding: Brown SD, Ecker JL, Ward JRM, et al. Am J Obstet Gynecol. 2013 Feb; 208(2):159.
Score: 0.286
-
Ethical dimensions of fetal neurology. Semin Fetal Neonatal Med. 2012 Oct; 17(5):252-5.
Score: 0.278
-
Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies. J Med Ethics. 2012 Jul; 38(7):397-8.
Score: 0.271
-
Dr. Goold's (2011) observations and criticisms. Letter to the editors. Am J Bioeth. 2012; 12(1):47-8.
Score: 0.269
-
A case study in unethical transgressive bioethics: "Letter of concern from bioethicists" about the prenatal administration of dexamethasone. Am J Bioeth. 2010 Sep; 10(9):35-45.
Score: 0.245
-
Ethical considerations in first-trimester Down syndrome risk assessment. Curr Opin Obstet Gynecol. 2010 Apr; 22(2):135-8.
Score: 0.238
-
Implementation of first-trimester risk assessment for trisomy 21: ethical considerations. Am J Obstet Gynecol. 2005 Jun; 192(6):1777-81.
Score: 0.171
-
Professionally responsible management of the ethical and social challenges of antenatal screening and diagnosis of ?-thalassemia in a high-risk population. J Perinat Med. 2021 Sep 27; 49(7):847-852.
Score: 0.127
-
An Ethical Framework for Research in Maternal-Fetal Intervention in the Presence of Maternal Human Immunodeficiency Virus or Hepatitis B and C Infection. Obstet Gynecol. 2019 01; 133(1):48-52.
Score: 0.109
-
Fetal analysis with invasive method (FA-I) and fetal analysis with non-invasive method (FA-NI): replacing current, deceptively imprecise clinical nomenclature. J Perinat Med. 2017 Nov 27; 45(8):985-987.
Score: 0.101
-
Rights-based reductionism--authors' reply. BJOG. 2013 Aug; 120(9):1153-4.
Score: 0.075
-
The intellectual and moral integrity of bioethics: response to commentaries on "A case study in unethical transgressive bioethics: 'Letter of concern from bioethicists' about the prenatal administration of dexamethasone". Am J Bioeth. 2010 Sep; 10(9):W3-5.
Score: 0.061
-
An ethically justified, clinically comprehensive management strategy for third-trimester pregnancies complicated by fetal anomalies. Obstet Gynecol. 1990 Mar; 75(3 Pt 1):311-6.
Score: 0.059
-
Ethics in obstetric ultrasound. J Ultrasound Med. 1989 Sep; 8(9):493-7.
Score: 0.057
-
Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing. Am J Med Genet C Semin Med Genet. 2007 Feb 15; 145C(1):99-104.
Score: 0.048
-
Ethics of research and the pregnant patient. Curr Womens Health Rep. 2003 Dec; 3(6):505-9.
Score: 0.038
-
Ethical issues in genetics and aging: diagnosis, treatment, and prevention in the era of molecular medicine. Generations. 2000; 24(1):72-8.
Score: 0.029
-
Evidence-based, ethically justified counseling for fetal bilateral renal agenesis. J Perinat Med. 2017 Jul 26; 45(5):585-594.
Score: 0.025
-
Evidence-Based Management of Patients with 45,X/46,XY Gonadal Dysgenesis and Male Sex Assignment: from Infancy to Adulthood. Pediatr Endocrinol Rev. 2016 Mar; 13(3):585-601.
Score: 0.022
-
Deliberative clinical ethical judgment: an essential component of contemporary obstetrics. J Perinat Med. 2013 Nov; 41(6):627-30.
Score: 0.019
-
Prenatal informed consent for sonogram: an indication for obstetric ultrasonography. Am J Obstet Gynecol. 1989 Oct; 161(4):857-60.
Score: 0.014
-
Nonaggressive obstetric management. An option for some fetal anomalies during the third trimester. JAMA. 1989 Jun 16; 261(23):3439-40.
Score: 0.014
-
Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge. Am J Obstet Gynecol. 2008 Jul; 199(1):19.e1-4.
Score: 0.013
-
Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol. 2004 Mar; 190(3):769-74.
Score: 0.010